First Report Customer Care 
All time: 4.6

Latest / Last 30 Days: 5.0

526 Reviews

Credit Rating - NORVIK PHARMACIES LIMITED

ANALYSIS
Credit Risk Update: SECURED CREDITOR INFORMATION: NORVIK PHARMACIES LIMITED, 79-81 BANDEATH INDUSTRIAL ESTATE, THROSK, STIRLING, FK7 7NP. The legal status is a Private Limited Company and the current status at the registry of companies is Active. The last filed accounts are dated 31 March 2022. The company was incorporated on 18 February 1988.

The accounts next due date is 31 December 2023. There are 4 mortgages, 3 satisfied, none part satisfied and 1 unsatisfied.

The above was based on public record information as at 11 September 2024 and may not reflect the current status. Please access the current report to ascertain the current status and credit rating.
SUMMARY
Registered Number: SC109313
Date Incorporated: 18 February 1988
Date Latest Accounts: 31 March 2022
BUSINESS INFORMATION
Legal Form: Private Limited Company
Previous Names: None
Registered Number: SC109313
Annual Return: 9 October 2015
Registered Office: 79-81 BANDEATH INDUSTRIAL ESTATE, THROSK, STIRLING, FK7 7NP
SIC Code and Operations: 47730
SECURED CREDITORS
Number of Mortgages 4
Satisfied Mortgages 3
Part Satisfied Mortgages 0
Unsatisfied Mortgages 1
CREDIT RISK RATING
This is the credit risk assessment used by one of the top UK credit reference agencies.
Risk Score (1-100):

NORVIK PHARMACIES LIMITED

Click Here

to view this information

Risk Assessment:
Credit Rating:



First Report Score: (0-10):

Financial Status Guide:
10  trafficlight Very Strong
9   Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical
Report Created On 21 September 2024 Copyright © 2024 First Report Ltd


Recent Searches

Reg No. Reg Name Status
02486429 NORVIK PRESS LIMITED Active
02398898 NORVIK REALISATIONS LIMITED Liquidation
SC656932 NORVIK TOPCO LIMITED Active
14638527 NORVIKEN LTD Active
14100904 NORVIL & JOSEPHINE PRODUCTIONS LTD Active

In using this service you agree to the Terms and Conditions

© 2024 First Report Ltd